Drug Patent Expirations for Jan 19 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
body { font-family:Calibri, tahoma, arial,
sans-serif;}table { font-size:12px; font-family:Calibri, tahoma, arial,
sans-serif; border-collapse:collapse; margin: 0px auto;}.xsnazzy h1,
.zsnazzy h1 { margin:0; font-size:1.2em; padding:0 10px 5px 10px;
border-bottom:1px solid #444; }.xsnazzy { background: transparent; margin:0
3px;}.xtop, .xbottom { display:block; background:transparent;
font-size:1px; }.xb1, .xb2, .xb3, .xb4 { display:block; overflow:hidden;
}.xb1, .xb2, .xb3 { height:1px; }.xb2, .xb3, .xb4 { background:#fff;
border-left:1px solid #444; border-right:1px solid #444; }.xb1 { margin:0
5px; background:#444; }.xb2 { margin:0 3px; border-width:0 2px; }.xb3 {
margin:0 2px; }.xb4 { height:2px; margin:0 1px;}.xboxcontent {
display:block; border:0 solid #444; border-width:0 1px; height:auto; }*
html .xboxcontent { height:1px; } td { padding:3px; } tr { border:.5pt;
background-color:#FFF; }

FDA Orange Book archives from 2005 to present

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents





Drug Patent Expirations for January 19 2013

Tradename Applicant Generic Name Patent
Expiration
IRESSA Astrazeneca gefitinib Jan 19, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.





DrugPatentWatch
Infographics

Which patents protect the most drugs

Which Patents Cover the Most
Drugs?

More
infographics &raquo






DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details


DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Click here for reuse options!
Copyright 2013 Biotechblog

Like this:


Comments are closed.

%d bloggers like this: